window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers & Shakers

  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    NanoSyrinx appoints Thomas Farrell as CEO

    NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

    January 14, 2026
  • Biotech,Clinical Development,Healthcare leadership,Movers & Shakers

    Novotech appoints Anand Tharmaratnam as CEO

    Novotech has appointed Anand Tharmaratnam as chief executive officer, following [...]

    January 14, 2026
  • Biotech,Central Nervous System,Healthcare leadership,Movers & Shakers,Neurosciences

    AstronauTx appoints Adam Rosenberg as Chair of the Board

    AstronauTx has appointed Adam Rosenberg as chair of the board, [...]

    January 14, 2026
  • Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers

    Qureight appoints Steven Bishop as Chief Medical Officer

    Qureight has appointed Steven Bishop as chief medical officer, marking [...]

    January 14, 2026
  • Clinical Development,Clinical Trials,Movers & Shakers,Oncology,Research & Development

    Syncromune appoints Stephen Dale as Chief Medical Officer

    Syncromune has appointed Stephen Dale as chief medical officer, strengthening [...]

    January 14, 2026
  • CDMOs & Manufacturing,Facilities and infrastructure,Healthcare leadership,Movers & Shakers

    AES Cleanroom Technology appoints Kristie Matevish as vice president of human resources

    AES Cleanroom Technology has appointed Kristie Matevish as vice president [...]

    January 14, 2026
  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology,Research & Development

    Mosaic Therapeutics appoints Stephen Shuttleworth as chief scientific officer

    Mosaic Therapeutics has appointed Stephen Shuttleworth as chief scientific officer [...]

    November 20, 2025
  • Biotech,Clinical Development,Drug Development,European biotech,Movers & Shakers,Oncology

    Ona Therapeutics appoints Antoine Yver as chair to steer ADC pipeline into clinical development

    Ona Therapeutics has appointed Antoine Yver as chair of its [...]

    November 19, 2025
  • Biotech,Cell & Gene Therapy,European biotech,Movers & Shakers

    Blue Cell Therapeutics appoints Miguel Forte to its board as it advances allogeneic cell therapies

    Blue Cell Therapeutics has added experienced cell therapy executive Miguel [...]

    November 14, 2025
  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing

    Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

    November 5, 2025
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top